Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.

Published online

Journal Article

OBJECTIVE: To evaluate access to treatment after community-based HPV testing as testing within screen-and-treat programs has the potential to lower mortality from cervical cancer in low-resource settings. METHODS: A prospective cohort study was conducted in western Kenya in 2018. Women aged 25-65 years underwent HPV self-testing. HPV-positive women were referred for cryotherapy. Participant data were obtained from questionnaires during screening and treatment. The proportion successfully accessing treatment and variables associated with successful treatment was determined. RESULTS: Of the 750 women included, 140 (18.6%) tested positive for HPV. Of them, 135 were notified of their results, of whom 77 (59.2%) sought treatment and 73 (52.1%) received cryotherapy. Women who received treatment had a shorter time from screening to result notification (median 92 days, interquartile range [IQR] 84-104) compared to those who did not (97 days, IQR 89-106; P=0.061). In adjusted analyses, women with a history of cervical cancer screening (odds ratio [OR] 11, 95% confidence interval [CI] 1.42-85.20) and those electing result notification through a home visit (OR 4, 95% CI 1.23-14.17) were significantly more likely to acquire treatment at follow-up. CONCLUSION: Linkage to treatment after community-based HPV screening in this population was low, highlighting the need for strategies aimed at strengthening treatment linkage in similar settings.

Full Text

Duke Authors

Cited Authors

  • Mungo, C; Ibrahim, S; Bukusi, EA; Truong, H-HM; Cohen, CR; Huchko, M

Published Date

  • April 29, 2020

Published In

PubMed ID

  • 32347550

Pubmed Central ID

  • 32347550

Electronic International Standard Serial Number (EISSN)

  • 1879-3479

Digital Object Identifier (DOI)

  • 10.1002/ijgo.13171

Language

  • eng

Conference Location

  • United States